Essity AB (publ)
OM-ESSITY B
Company Overview
Essity AB (publ) develops, produces, and sells hygiene and health products and services worldwide. It offers health and medical products, including incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology. It operates in Personal Care, Consumer Tissue, Professional Hygiene, and Other segments. The company also provides consumer goods, such as incontinence products, pads, diapers, wet wipes, skincare products, intimate soaps, washable absorbent underwear, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins; and professional hygiene products that consist of toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products. In addition, it offers digital solutions, such as Internet of Things sensor technology enabling data-driven cleaning, as well as related service and maintenance to companies and office buildings, universities, healthcare facilities, industries, restaurants, hotels, stadiums, and other public venues. The company markets its health and medical products under the TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Castbrands brands through pharmacies, medical devices stores, hospitals, distributors, and care institutions, as well as e-commerce; consumer goods products under the Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda brands through retail trade and online; and professional hygiene products under the TORK brand through distributors and online. It serves in Europe, North America, Latin America, Asia, and internationally. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.
Name
Essity AB (publ)
CEO
Ulrika Kolsrud
Website
www.essity.com
Sector
Household Products
Year Founded
1849
Company Statistics
Profile
Market Cap
—
EV
—
Shares Out
—
Revenue
—
Employees
—
Margins
Gross
—
EBITDA
—
Operating
—
Pre-Tax
—
Net
—
FCF
—
Returns (5Yr Avg)
ROA
—
ROTA
—
ROE
—
ROCE
—
ROIC
—
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
—
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
—
Net Debt
—
Debt/Equity
—
EBIT/Interest
—
Growth (CAGR)
Rev 3Yr
—
Rev 5Yr
—
Rev 10Yr
—
Dil EPS 3Yr
—
Dil EPS 5Yr
—
Dil EPS 10Yr
—
Rev Fwd 2Yr
—
EBITDA Fwd 2Yr
—
EPS Fwd 2Yr
—
EPS LT Growth Est
—
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—
Bulls Say
We think favorable demographic trends and higher disposable income in emerging markets will drive long-term per capita growth of health and hygiene products.
Essity exited markets where it failed to capture significant market share, giving us confidence that management prioritizes long-term ROICs over potentially margin-dilutive top-line growth.
Essity’s leading incontinence brand, Tena, should be able to maintain demand amid an aging global population, driving high-single-digit growth in the higher-margin personal care segment.
Bears Say
Essity is exposed to volatile input costs such as pulp and is not always able to pass on costs in the short term, leading to volatile earnings.
With a mix of commoditized products, volumes could decline if consumers trade out or down from Essity's fare in a more challenging economic climate.
We believe the price paid by Essity for the Knix acquisition in 2022 was excessive, leading to shareholder value destruction.